Connection
Andres Henao Martinez to Vancomycin
This is a "connection" page, showing publications Andres Henao Martinez has written about Vancomycin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.191 |
|
|
|
-
Salam ME, Chastain DB, Fish D, Henao-Martínez AF, Krsak M, Miller M, Morrisette T, Mueller S, Krsak M. Long-Acting Lipoglycopeptide Treatment of Invasive Gram-Positive Infections. Drugs. 2026 Sep; 86(9):1421-1434.
Score: 0.056
-
Krsak M, Klimpl D, Mueller SW, Morrisette T, Grimshaw AA, Chastain D, Steuber T, Sah R, Henao-Martinez AF, Molina KC. Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta-Analysis of Observational Studies. Pharmacotherapy. 2025 11; 45(11):754-763.
Score: 0.054
-
Jackson BT, Cluck DB, Henao-Martínez AF, Chastain DB. Kimyrsa and Orbactiv - A Tale of Two Formulations. Drug Des Devel Ther. 2023; 17:737-742.
Score: 0.045
-
Thomas G, Henao-Martínez AF, Franco-Paredes C, Chastain DB. Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review. Int J Antimicrob Agents. 2020 Sep; 56(3):106069.
Score: 0.037
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|